Clinical Trial Update: "Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of selinexor, pegaspargase, and dexamethasone for extranodal natural killer/T-cell lymphoma, nasal type, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pegaspargase (pegaspargase)
• Selinexor (selinexor)

Snippet

Sponsor: Mingzhi Zhang | Conditions: NKTCL, Selinexor | Phase 1, Phase 2 | Status: RECRUITING